Urteste (URT) Stock Overview
Engages in the research and development of diagnostic tests for cancers. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
URT Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Urteste S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł49.20 |
| 52 Week High | zł107.00 |
| 52 Week Low | zł45.00 |
| Beta | -0.056 |
| 1 Month Change | -3.53% |
| 3 Month Change | -38.04% |
| 1 Year Change | -43.32% |
| 3 Year Change | -44.09% |
| 5 Year Change | n/a |
| Change since IPO | -50.20% |
Recent News & Updates
Here's Why We're Watching Urteste's (WSE:URT) Cash Burn Situation
May 27
Is Urteste (WSE:URT) In A Good Position To Invest In Growth?
Dec 07Urteste (WSE:URT) Is In A Good Position To Deliver On Growth Plans
Jul 19Shareholder Returns
| URT | PL Biotechs | PL Market | |
|---|---|---|---|
| 7D | 7.0% | 0.9% | -1.3% |
| 1Y | -43.3% | -13.1% | 13.3% |
Return vs Industry: URT underperformed the Polish Biotechs industry which returned -13.1% over the past year.
Return vs Market: URT underperformed the Polish Market which returned 13.3% over the past year.
Price Volatility
| URT volatility | |
|---|---|
| URT Average Weekly Movement | 9.5% |
| Biotechs Industry Average Movement | 5.8% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in PL Market | 11.7% |
| 10% least volatile stocks in PL Market | 3.3% |
Stable Share Price: URT's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: URT's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 33 | Grzegorz Stefanski | www.urteste.com |
Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland.
Urteste S.A. Fundamentals Summary
| URT fundamental statistics | |
|---|---|
| Market cap | zł69.50m |
| Earnings (TTM) | -zł3.04m |
| Revenue (TTM) | zł1.54m |
Is URT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| URT income statement (TTM) | |
|---|---|
| Revenue | zł1.54m |
| Cost of Revenue | zł252.00k |
| Gross Profit | zł1.29m |
| Other Expenses | zł4.33m |
| Earnings | -zł3.04m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.16 |
| Gross Margin | 83.60% |
| Net Profit Margin | -197.85% |
| Debt/Equity Ratio | 0% |
How did URT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/11 18:10 |
| End of Day Share Price | 2025/07/11 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Urteste S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sylwia Jaskiewicz | Dom Maklerski Banku Ochrony Srodowiska S.A. |